Research graph
References from Pleuroparenchymal fibroelastosis in a UK tertiary ILD centre: determinants of radiological progression and survival. Local targets link to admitted publications; unresolved targets remain external evidence.
Pleuroparenchymal Fibroelastosis: Its Clinical Characteristics
10.2174/1573398x0904140129125307 · 2013 · External reference
An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias
10.1164/rccm.201308-1483st · 2013 · External reference
Pleuroparenchymal fibroelastosis
10.1097/mcp.0000000000000907 · 2022 · External reference
Proposed Clinical Algorithm for Pleuroparenchymal Fibroelastosis (PPFE)
10.3390/jcm13133675 · 2024 · External reference
Upper lobe fibrosis: a novel manifestation of chronic allograft dysfunction in lung transplantation
10.1016/j.healun.2004.08.026 · 2005 · External reference
Fibrosis of the upper lobes: a newly identified late-onset complication after lung transplantation?
10.2214/ajr.181.6.1811539 · 2003 · External reference
Pleuroparenchymal fibroelastosis as a late complication of chemotherapy agents
10.1183/09031936.00214713 · 2014 · External reference
Radiologic pleuroparenchymal fibroelastosis-like lesion in connective tissue disease-related interstitial lung disease
10.1371/journal.pone.0180283 · 2017 · External reference
Functional associations of pleuroparenchymal fibroelastosis and emphysema with hypersensitivity pneumonitis
10.1016/j.rmed.2018.03.031 · 2018 · External reference
Distinct characteristics of pleuroparenchymal fibroelastosis with usual interstitial pneumonia compared with idiopathic pulmonary fibrosis
10.1378/chest.13-2866 · 2014 · External reference
PPFE-like findings identify an IPF subgroup with shortened telomeres and poor prognosis
2026 · External reference
Telomere-related lung fibrosis is diagnostically heterogeneous but uniformly progressive
10.1183/13993003.00308-2016 · 2016 · External reference
Pleuroparenchymal fibroelastosis associated with telomerase reverse transcriptase mutations
10.1183/13993003.02022-2016 · 2017 · External reference
Pleuroparenchymal fibroelastosis: a spectrum of histopathological and imaging phenotypes
10.1183/09031936.00165111 · 2012 · External reference
Usual Interstitial Pneumonia Pattern in the Lower Lung Lobes as a Prognostic Factor in Idiopathic Pleuroparenchymal Fibroelastosis
10.1159/000494061 · 2019 · External reference
Pleuroparenchymal fibroelastosis in patients with idiopathic pulmonary fibrosis
10.1111/resp.13796 · 2020 · External reference
Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults: An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline
10.1164/rccm.202202-0399st · 2022 · External reference
Treatment with antifibrotic agents in idiopathic pleuroparenchymal fibroelastosis with usual interstitial pneumonia
10.1183/23120541.00196-2020 · 2021 · External reference
Idiopathic pleuroparenchymal fibroelastosis: description of a novel clinicopathologic entity
10.1378/chest.126.6.2007 · 2004 · External reference
Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline
10.1164/rccm.201807-1255st · 2018 · External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
Delineating associations of progressive pleuroparenchymal fibroelastosis in patients with pulmonary fibrosis
10.1183/23120541.00637-2022 · 2023 · External reference
Poorer Prognosis of Idiopathic Pleuroparenchymal Fibroelastosis Compared with Idiopathic Pulmonary Fibrosis in Advanced Stage
2018 · External reference
Pleuroparenchymal fibroelastosis: so many unmet needs
10.1183/13993003.01798-2022 · 2022 · External reference
[Seven cases of marked pulmonary fibrosis in the upper lobe]
1999 · External reference
Telomere Length Regulation
10.3389/fonc.2022.943622 · 2022 · External reference
Shortened Telomere Length as a Risk Factor for Idiopathic Pulmonary Fibrosis: A Meta-Analysis
10.2174/0118743064421488251017061020 · 2026 · External reference
Distinct profile and prognostic impact of body composition changes in idiopathic pulmonary fibrosis and idiopathic pleuroparenchymal fibroelastosis
10.1038/s41598-018-32478-z · 2018 · External reference
Disease course and prognosis of pleuroparenchymal fibroelastosis compared with idiopathic pulmonary fibrosis
10.1016/j.rmed.2020.106078 · 2020 · External reference
Prognostic and Clinical Value of Cluster Analysis in Idiopathic Pleuroparenchymal Fibroelastosis Phenotypes
10.3390/jcm10071498 · 2021 · External reference
A proposed prognostic prediction score for pleuroparenchymal fibroelastosis
10.1186/s12931-021-01810-z · 2021 · External reference
Idiopathic pleuroparenchymal fibroelastosis: three-dimensional computed tomography assessment of upper-lobe lung volume
10.1183/13993003.00637-2022 · 2022 · External reference
Nintedanib in Progressive Fibrosing Interstitial Lung Diseases
2020 · External reference
Nintedanib in idiopathic and secondary pleuroparenchymal fibroelastosis
10.1186/s13023-021-02043-5 · 2021 · External reference
Limited efficacy of nintedanib for idiopathic pleuroparenchymal fibroelastosis
10.1016/j.resinv.2022.03.001 · 2022 · External reference
Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis
10.1056/nejmoa1402584 · 2014 · External reference
A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis
10.1056/nejmoa1402582 · 2014 · External reference
Minimum sample size for developing a multivariable prediction model: PART II - binary and time-to-event outcomes
10.1002/sim.7992 · 2019 · External reference
A simulation study of the number of events per variable in logistic regression analysis
10.1016/s0895-4356(96)00236-3 · 1996 · External reference
